Des-γ-carboxy Prothrombin in hepatocellular carcinoma post-operative recurrence risk evaluation
These results expand on the clinical utilization of the hepatocellular carcinoma diagnosis biomarker, Des-γ-carboxy prothrombin, by proposing a quantification measurement of Des-γ-carboxy prothrombin dynamics to monitor hepatocellular carcinoma recurrence. This measurement is not limited in prognosis but can also improve the sensitivity of early hepatocellular carcinoma screening.
Authors
- Zhenli Li (ORCID: https://orcid.org/0000-0002-3682-164X)
- Jianyang Zeng (ORCID: https://orcid.org/0000-0003-0950-7716)
- Liman Qiu (ORCID: https://orcid.org/0000-0003-4332-1843)
- Pengfei Guo (ORCID: https://orcid.org/0000-0002-4618-6803)
- Xinting Pan (ORCID: https://orcid.org/0000-0003-2733-1064)
- Xiaolong Liu (ORCID: https://orcid.org/0000-0002-3096-4981)
- Geng Chen (ORCID: https://orcid.org/0000-0002-2320-2161)
- En Hu (ORCID: https://orcid.org/0000-0002-1000-7260)
- Yang Zhou (ORCID: https://orcid.org/0000-0002-7076-9056)
- Xiuqing Dong (ORCID: https://orcid.org/0000-0001-7510-1904)
- Zhixiong Cai (ORCID: https://orcid.org/0000-0002-0912-8372)
Institutions
- Fujian Medical University (CN)
- Mengchao Hepatobiliary Hospital (CN)
Publication Details
- Journal
- Communications Medicine
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1038/s43856-025-00784-z
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 2.64